ArticleTranslational cancer research2025
Pulmonary metastasis risk and overall survival score in choriocarcinoma: a novel nomogram-based risk assessment system.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: At present, the risk of developing pulmonary metastasis and prognostic factors for choriocarcinoma (CC) remain unclear. This study aimed to investigate the independent risk factors and prognostic factors for pulmonary metastasis of CC and to construct a prognostic prediction model. Methods: We retrieved data on patients diagnosed with CC between 2010 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regressions were used to identify independent risk factors for developing pulmonary metastases in CC. Then, univariate and multivariate COX regression analyses were used to identify independent risk factors affecting the prognosis of patients with CC. Finally, we constructed a predictive nomogram and assessed the efficacy of the nomogram by receiver operating characteristic (ROC) curves, calibration curves, and decision analysis curves (DCAs). Results: Independent risk factors for developing pulmonary metastases in CC patients were gender and tissue type. Independent risk factors for the prognosis of CC patients were age, marriage, primary location, liver metastases, lung metastases, and surgical intervention. The results of ROC curves, calibration curves, and DCA in the training and validation groups confirmed that the nomogram could accurately predict the prognosis of CC patients. Conclusions: Patients with CC are more likely to be young, have a more primary male genital system, have a poor prognosis, and are most likely to be complicated by pulmonary metastasis at initial diagnosis. A novel prediction model to predict the prognosis of CC patients has been constructed to personalize and guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.